Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Lactated Ringer’s Administration Improved Outcomes Over Normal Saline Administration During Sickle Cell Vaso-Occlusive Episode

Clinical question: Is there a difference in the effectiveness of sickle cell vaso-occlusive episode treatment with lactated Ringer’s (LR) solution versus normal saline (NS)?

Background: Initial treatment of a sickle cell vaso-occlusive episode includes fluid resuscitation. While the choice of fluids is clinician-dependent, the majority of clinicians choose NS. However, some studies suggest that NS may actually promote erythrocyte sickling.

Study design: Multi-center retrospective cohort study

Setting: Hospitals from all four U.S. Census regions

Synopsis: Using the Premier PINC AI database, a total of 55,574 encounters of adults with primary ICD-10 codes for sickle cell disease and vaso-occlusive events who received either NS or LR on day one were identified. Analysis of these encounters revealed that the use of LR for fluid resuscitation had a small but significant improvement in primary outcomes (more hospital-free days) and secondary outcomes (shorter hospital stay, lower 30-day readmission rate, more IV-opioid-free days) when compared to the use of NS for fluid resuscitation.

Limitations included that, given the reliance on ICD-10 codes for population selection, this study could be subject to misclassification. Also, the volume status of included patients on presentation was unknown. This study provides guidance on the type of fluid to use in initial resuscitation, not the amount of fluid resuscitation necessary for adequate resuscitation.

Bottom line: Vaso-occlusive episodes in the setting of sickle cell disease treated with LR for initial fluid resuscitation have improved outcomes compared to those treated with NS.

Citation: Alwang AK, et al. Lactated Ringer vs normal saline solution during sickle cell vaso-occlusive episodes. JAMA Intern Med. 2024;184(11):1365-1372. doi:10.1001/jamainternmed.2024.4428.

Dr. Djekic is a hospitalist and a clinical assistant professor in the division of hospital medicine at UC San Diego Health at the University of California in San Diego.

  • Lactated Ringer’s Administration Improved Outcomes Over Normal Saline Administration During Sickle Cell Vaso-Occlusive Episode

    May 1, 2025

  • Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients

    May 1, 2025

  • Beta-Blocker Interruption or Continuation after Myocardial Infarction

    May 1, 2025

  • Stewardship Prompts to Improve Antibiotic Selection for UTI

    May 1, 2025

  • Non-Medical Consequences: The 6th Element of Informed Consent

    May 1, 2025

  • JHM’s Progress Notes

    May 1, 2025

  • AAPI Heritage Hospitalists Reflect on Their Life and Professional Experiences

    May 1, 2025

  • 2025 Masters in Hospital Medicine

    May 1, 2025

  • The Transformative Role of POCUS in Hospital Medicine

    May 1, 2025

  • The Committee That Could: A Model for Rapid Service Structure Change

    May 1, 2025

1 … 11 12 13 14 15 … 973
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences